Dani leads Pharmaco- and Device Epidemiology research at NDORMS and is currently investigating the use, safety, and effectiveness of COVID-19 therapies and vaccines.
On being elected to the Board, Dani said "Being elected as the Academic representative for Europe/Africa is a great opportunity and a responsibility. Setting the standards for research into the safety of medicines and vaccines is more important now than ever. I will be delighted to represent the values of academia in the BoD to make sure ISPE continues to be a welcoming, inclusive society that strives to improve the quality and methodological standards of pharmacoepidemiology globally."
ISPE is a large international scientific society that sets the basis for methodological and clinical research into the use and the effects of medicines in routine practice settings. The ISPE Board of Directors decides on all aspects related to the management and planning of ISPE's activities.